| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1995) |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN Prodrug |
| ATC: | J01FA13 |
| UNII: | 1801D76STL |
| InChI Key | WLOHNSSYAXHWNR-GDLCQVGZSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C42H78N2O14 |
| Molecular Weight | 835.09 |
| AlogP | 2.2 |
| Hydrogen Bond Acceptor | 16.0 |
| Hydrogen Bond Donor | 5.0 |
| Number of Rotational Bond | 12.0 |
| Polar Surface Area | 196.33 |
| Molecular species | BASE |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 58.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Bacterial 70S ribosome inhibitor |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Transferase
|
- | - | - | - | ||
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIb
|
- | - | - | - | -8.43-11.46 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 109.07 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Osteomyelitis | 1 | D010019 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 62013-04-1 |
| ChEBI | 474014 |
| ChEMBL | CHEMBL1237072 |
| DrugBank | DB00954 |
| DrugCentral | 925 |
| FDA SRS | 1801D76STL |
| PDB | DI0 |
| PubChem | 6473883 |
| ZINC | ZINC000096095661 |